Early detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulating in the bloodstream—the so-called “liquid biopsy”—has become a research focal point. But using this method to detect cancer at its early stages has been challenging due to low tumor…
in Health
Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples
